Synthetic cannabinoids and seizures in the UK and Europe remain an important public-health concern. Products sold under names such as K2, Spice, synthetic cannabis, herbal incense or liquid incense may contain potent laboratory-made chemicals that act on cannabinoid receptors in the brain. Their contents can vary substantially between packets, batches and regions.
Seizures are among the most serious possible effects. They may occur after smoking or vaping a synthetic cannabinoid, after exposure to a highly concentrated liquid, or alongside other complications such as overheating, agitation, heart rhythm changes or loss of consciousness. A product labelled “herbal” or “legal” should never be treated as proof of safety.
This article is for education and harm reduction. It does not encourage the use, possession or supply of psychoactive substances. If someone is having a seizure now, call 999 in the UK or 112 in the EU and wider Europe.
What are synthetic cannabinoids?
Synthetic cannabinoids are a broad group of manufactured chemicals designed to interact with the body’s cannabinoid receptors. Some early compounds, including JWH-018 and related members of the JWH series, were used in research. They are not the same as THC, the main intoxicating cannabinoid in cannabis, and their effects cannot be reliably predicted from the product name or packaging.
In commercial settings, the chemicals may be applied to dried plant material, paper, powders or vape liquids. The finished products are sometimes marketed as herbal incense, potpourri, aroma products or research materials. However, the label may not accurately identify the active ingredient, concentration or potential contaminants.
Unlike regulated medicines, many synthetic cannabinoid products have no dependable consumer information about dose, purity or interactions. A packet bearing the same brand name can contain a different compound from an earlier batch. That variability is one reason why a previously tolerated product does not guarantee a safe experience on another occasion.
How can synthetic cannabinoids trigger seizures?
The precise mechanism may differ between compounds, but several factors can contribute to seizure risk:
- Strong receptor activity: Some synthetic cannabinoids activate cannabinoid receptors more powerfully or for longer than THC. Excessive stimulation can disrupt normal brain signalling.
- Unknown concentration: Uneven application to plant material or paper can create concentrated areas. A person may inhale far more active chemical than expected from a small amount.
- Unidentified ingredients: Products can contain multiple synthetic cannabinoids, residual solvents or other psychoactive substances. The combination may increase neurological stress.
- Overheating and dehydration: Agitation, prolonged activity, hot environments and reduced fluid intake can lower the threshold for a seizure.
- Polydrug use: Alcohol, stimulants, prescription medicines and other drugs may alter seizure risk or make symptoms more severe.
- Individual vulnerability: A history of epilepsy, head injury, sleep deprivation, metabolic illness or previous unexplained seizures may increase susceptibility.
It is not possible to identify seizure risk simply by smell, colour, appearance or a brand name. Even experienced users may be unable to distinguish a lower-risk herbal smoking blend from material treated with a potent synthetic cannabinoid.
What does a synthetic cannabinoid-related seizure look like?
A generalised seizure may begin with a sudden collapse and loss of awareness. The person may become stiff, followed by rhythmic jerking of the arms and legs. Breathing can appear irregular, and the lips may look blue or grey for a short period. Afterward, the person may be confused, exhausted, emotional or difficult to wake.
Not every seizure involves dramatic shaking. Other signs can include:
- Sudden staring, unresponsiveness or unusual repetitive movements
- Muscle stiffening without obvious jerking
- Loss of bladder control
- Unexplained injury, tongue biting or blood around the mouth
- Confusion, severe drowsiness or memory loss after an episode
- Repeated episodes close together
People affected by K2 or Spice may also show extreme agitation, paranoia, hallucinations, vomiting, chest pain, a very fast heartbeat or dangerous overheating. These symptoms can accompany a seizure or indicate another medical emergency.
What to do during a seizure
First, protect the person from immediate injury and ask someone to call emergency services. The following steps are recommended:
- Move nearby furniture, glass, sharp objects and hot items away if this can be done safely.
- Cushion the head with clothing or a soft object.
- Loosen tight clothing around the neck.
- Time the seizure from the beginning of the movements.
- When the jerking stops, place the person on their side in the recovery position and check that they are breathing normally.
- Stay with them, speak calmly and provide responders with information about what may have been taken.
Do not restrain the person, place anything in their mouth, give food or drink, attempt to make them vomit, or move them unless there is an immediate danger such as fire or traffic. Do not assume that a seizure has ended simply because the movements have stopped; the person may remain unconscious or have difficulty breathing.
When is a seizure an emergency?
Call 999 or 112 immediately if the seizure lasts five minutes or longer, another seizure follows before the person recovers, the person is injured, breathing is abnormal, the episode occurs in water, or the person is pregnant, diabetic or known to have taken a synthetic cannabinoid or another drug.
Emergency help is also essential when this is the person’s first suspected seizure. A synthetic cannabinoid exposure can cause complications that are not visible from the outside, including heart problems, kidney injury, severe dehydration or dangerously high body temperature.
Why K2 and Spice seizures can be difficult to assess
In the UK and Europe, emergency clinicians may encounter products sold under rapidly changing names. “K2”, “Spice”, “Black Mamba”, “c-liquid” and other labels do not necessarily describe a consistent chemical formulation. A product may also be sold as an incense blend while being used by consumers for inhalation.
Routine drug screens often do not detect newer synthetic cannabinoids. A negative standard cannabis test therefore does not rule out exposure. Medical staff should be told about the packaging, product name, approximate time of use and any co-consumed substances. Keeping the packet or a photograph of it can help with identification, but do not delay emergency care to find it.
It is especially important to disclose vaping or liquid exposure. Synthetic cannabinoid vape liquid and C-liquid can be highly concentrated, and accidental skin, mouth or eye contact may also require urgent advice. Do not handle spilled liquid with bare hands.
Reducing the chance of a serious outcome
The only reliable way to avoid synthetic cannabinoid-related seizure risk is not to use these products. This includes products advertised as “strong”, “extra potent”, “legal highs”, “research chemicals” or “natural incense”. Legal status and marketing language do not provide a medical safety guarantee.
For people who may use despite the risks, practical harm-reduction measures include avoiding use alone, avoiding combinations with alcohol or stimulants, and not driving or operating machinery. Never assume that a small amount is safe when concentration is unknown. Avoid use when sleep-deprived, unwell, overheated or dehydrated, and ensure that someone present knows how to call emergency services.
These measures cannot make an unpredictable product safe. They are intended only to reduce the likelihood of delayed assistance or preventable injury. People with epilepsy, a previous seizure, serious mental-health symptoms, heart disease or a history of drug poisoning should seek medical advice before any exposure to psychoactive substances.
Understanding herbal incense labels
Some herbal incense products are marketed for aromatic purposes only, while other products may be associated with synthetic cannabinoid terminology. Consumers should read packaging carefully and treat claims such as “not for human consumption” as a legal or marketing statement rather than evidence that the contents are harmless.
For general product and category information, readers can visit the K2 Herbal Highs home page, review the site’s product information index or browse the product category index. These pages should not replace independent checks of local law, product composition or health advice. Psychoactive synthetic cannabinoids are restricted or controlled in many UK and European jurisdictions.
After a seizure: what happens next?
A person who has experienced a suspected drug-related seizure should receive medical assessment, even if they seem recovered. Clinicians may check breathing, temperature, blood glucose, heart rhythm, hydration and neurological status. Further tests may be needed to investigate injury, infection, metabolic problems or an underlying seizure disorder.
After discharge, avoid further exposure until a healthcare professional has provided advice. Repeated use can be followed by anxiety, insomnia, low mood, irritability or other withdrawal symptoms. If someone is finding it difficult to stop, a GP, local drug and alcohol service or specialist addiction service can provide confidential support in the UK. Equivalent services are available through national health systems across Europe.
Friends and family should avoid judgement and focus on safety. Ask whether the person has ongoing confusion, weakness, breathing problems, chest pain or another seizure. If any of these occur, seek emergency help again.
Frequently asked questions
Can synthetic cannabinoids cause seizures after one use?
Yes. Seizures have been reported after single exposures, particularly when the product contains a potent or unevenly distributed chemical. A person does not need a known history of epilepsy for a seizure to occur.
Are K2 and Spice safer than cannabis?
No. K2 and Spice are informal names often used for products containing synthetic cannabinoids. Their effects can be more intense and less predictable than those associated with cannabis because the ingredients and concentrations may be unknown.
Can a standard cannabis drug test detect synthetic cannabinoids?
Usually not. Standard tests generally target cannabis metabolites rather than the wide and changing range of synthetic cannabinoids. Specialist testing may be required, but medical treatment should never be delayed while waiting for test results.
Should someone eat or drink after a seizure?
Not while they are confused, drowsy or not fully alert. They could choke. Wait until they are awake and able to swallow safely, and follow the instructions of emergency responders or healthcare professionals.
What is the most important response to a suspected synthetic cannabinoid seizure?
Protect the person from injury, time the seizure, place them on their side once movements stop, and call 999 or 112 when emergency criteria apply. Tell responders honestly what may have been used, including any vape liquid, powder, paper or herbal blend.
Key points
- Synthetic cannabinoids are not the same as THC and can vary widely between products.
- Seizures may occur after one exposure and can be accompanied by overheating, agitation or heart problems.
- Never put anything in a person’s mouth or restrain them during a seizure.
- Call 999 in the UK or 112 in Europe for a first seizure, a prolonged seizure, repeated seizures or breathing difficulties.
- Product names, “herbal” labels and legal-high claims cannot confirm safety or contents.
